Toggle navigation
Home
Search
Services
Blog
Contact
About
Biomedical Accelerator Mass Spectrometer for C14 and H3
Klinkowstein, Robert E.
Newton Scientific, Inc., Cambridge, MA, United States
Search 5 grants from Robert Klinkowstein
Search grants from Newton Scientific, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
GH16-002, Botswana: Impact Evaluation of Combination HIV Prevention Interventions
Improving Transplant Med Safety through a Pharmacist-Led, mHealth-Based Program
Psychobiology, Self-regulatory &Psychopathology
Novel Functions of Red Cell Proteins Lu and LW
Development of Educational Materials for Quick Response Component Supply
Recently added grants:
Maximizing Effectiveness of Case Management in Primary Care for Rural Veterans
Acamprosate pharmacogenomics: iPSC based model of alcohol use disorder
Medication Adherence After Stroke
Mechanisms of inflammation in lipid-laden macrophages after spinal cord injury
Defining how Microbes Drive Abnormal T Cell Responses in Rheumatoid Arthritis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA066400-02
Application #
2109759
Study Section
Special Emphasis Panel (ZRG3-SSS-6 (13))
Project Start
1995-02-03
Project End
1998-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Newton Scientific, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02141
Related projects
NIH 1997
R44 CA
Biomedical Accelerator Mass Spectrometer for C14 and H3
Klinkowstein, Robert E. / Newton Scientific, Inc.
NIH 1996
R44 CA
Biomedical Accelerator Mass Spectrometer for C14 and H3
Klinkowstein, Robert E. / Newton Scientific, Inc.
Comments
Be the first to comment on Robert Klinkowstein's grant